medicationPrescription only (US)
AtorvastatinBenefits, Dosage & Interactions
Also known as: lipitor
Atorvastatin, marketed often under the brand name Lipitor, is a member of the drug class known as statins or HMG-CoA reductase inhibitors. It is a prescription medication primarily used to lower high levels of cholesterol and triglycerides in the blood.
Researched by DoseRoutine R&D TeamReviewed for accuracy by Nicholas Alexander, RSELast updated
Evidence: Moderate — One published human randomized trial; results not yet replicated.
Evidence strengthModerate · 3/4
PreclinicalStrong human evidence
One published human randomized trial; results not yet replicated.
Plasma half-life
~14 h
Typical timing
evening
Default unit
mg
What published protocols report
Ranges documented in the literature, shown for reference. DoseRoutine does not recommend an amount — your prescriber or the product label sets the dose.
- Reported amounts
- The cited randomized trial used atorvastatin 10 mg once daily in hypertensive patients with average or lower-than-average cholesterol[1]
- Route studied
- Oral[1]
- Frequency
- Once daily in the cited trial[1]
- Cycle length
- Median follow-up of 3.3 years in the cited trial[1]
- Half-life
- Roughly 14 hours[1]
- Storage
- Room temperature, sealed[1]
Reported for Atorvastatin in the cited sources. Published ranges are not dosing advice.
References & evidence
Documents the Atorvastatin entry is written from. Each number matches an inline marker above.
- [1]Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trialSever PS, Dahlof B, Poulter NR, et al. · Lancet · 2003 · Peer-reviewed · PMID 12686036
How to track Atorvastatin doses
Tracking Atorvastatin well takes four fields and a habit. Here is what to record so the log is still useful in three months.
- 1
Add the dose and unit
Log Atorvastatin with its dose in mg so totals stay comparable over time — including days when you split the dose or skip it.
- 2
Set the time of day and food rule
Typical timing is evening. Reminders fire at that time and can export to your calendar.
- 3
Check it against the rest of the stack
Run Atorvastatin through the interaction checker against everything else in the routine — supplements, peptides, hormones and prescriptions — before it becomes a daily habit.
- 4
Log adherence, not intentions
Mark each dose taken, skipped or delayed as it happens. Weeks of honest logs are what make an adherence rate or a trend line meaningful; retrospective guessing is not.
- 5
Review against outcomes
With a reported half-life around 14 h, effects and timing shifts show up over days rather than instantly. Review Atorvastatin alongside your logged metrics and any relevant blood work every few weeks before changing the dose.
What to log each time
- Dose in mg
- Time of day
- Taken / skipped / delayed
- Any side effects or notable changes
References & Evidence
Sources on this page that document Atorvastatin dosing, timing and safety.
- [1]National Center for Biotechnology Information View source
Educational information only — not medical advice. Dose ranges vary by person, indication and prescriber.
What is Atorvastatin?Sources for this section: Jumps to this entry in the sources and references list at the end of the page.
Atorvastatin, marketed often under the brand name Lipitor, is a member of the drug class known as statins or HMG-CoA reductase inhibitors. It is a prescription medication primarily used to lower high levels of cholesterol and triglycerides in the blood. By reducing these lipid levels, atorvastatin helps decrease the risk of heart disease, stroke, and other cardiovascular events. It is often prescribed as an adjunct to diet and exercise when lifestyle modifications alone are insufficient to manage lipid levels (NIH MedlinePlus). Atorvastatin works by inhibiting a key enzyme involved in cholesterol production in the liver. It has been widely studied for its efficacy in both primary and secondary prevention of cardiovascular disease.
What does the research say about Atorvastatin?
Tap a section to expand.
Atorvastatin functions as a selective, competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. This enzyme catalyzes the conversion of HMG-CoA to mevalonate, an early and rate-limiting step in cholesterol biosynthesis within the liver. By inhibiting HMG-CoA reductase, atorvastatin reduces the amount of cholesterol produced by liver cells. This reduction in hepatic cholesterol synthesis leads to an upregulation of low-density lipoprotein (LDL) receptors on the surface of liver cells. These receptors then remove more LDL-cholesterol from the bloodstream, thereby lowering plasma LDL-C concentrations. Atorvastatin also reduces very low-density lipoprotein (VLDL) production and triglyceride levels, and it can increase high-density lipoprotein (HDL) cholesterol in some individuals (FDA label, DrugBank). The overall effect is a significant reduction in total cholesterol, LDL-cholesterol, and triglycerides.
Source for this section: Sources for How does Atorvastatin work?: Jumps to this entry in the sources and references list at the end of the page.
The primary benefits of atorvastatin stem from its ability to effectively lower cholesterol and triglyceride levels. These benefits include:
* **Reduction in LDL-C (bad cholesterol):** Atorvastatin is highly effective at lowering LDL-C, which is a major risk factor for atherosclerosis and cardiovascular disease (CVD).
* **Lowered risk of heart attack and stroke:** By reducing LDL-C and other lipid parameters, atorvastatin significantly decreases the incidence of major cardiovascular events, including myocardial infarction (heart attack) and ischemic stroke (Cochrane Review).
* **Prevention of cardiovascular disease:** It is used for both primary prevention (in individuals at high risk but without established CVD) and secondary prevention (in individuals who have already experienced a cardiovascular event to prevent recurrence) (Mayo Clinic).
* **Management of hypertriglyceridemia:** Atorvastatin can also effectively lower elevated triglyceride levels, particularly when they are associated with high LDL-C.
* **Improved lipid profiles in specific conditions:** It is used in conditions like primary hypercholesterolemia, mixed dyslipidemia, and homozygous familial hypercholesterolemia to improve lipid markers and reduce associated risks (FDA label).
Atorvastatin's efficacy and safety have been extensively evaluated in numerous clinical trials and observational studies. Key evidence supporting its use includes:
* **ASCOT-LLA (Anglo-Scandinavian Cardiac Outcomes Trial – Lipid Lowering Arm):** This large-scale, randomized controlled trial demonstrated that atorvastatin significantly reduced the risk of nonfatal myocardial infarction and fatal coronary heart disease in hypertensive patients with multiple cardiovascular risk factors but average cholesterol levels (PubChem).
* **CARDS (Collaborative Atorvastatin Diabetes Study):** This study showed that atorvastatin significantly reduced the risk of major cardiovascular events in patients with type 2 diabetes without a history of heart disease but with at least one additional risk factor (Examine.com).
* **TNT (Treating to New Targets) study:** This trial compared the effects of 10 mg versus 80 mg of atorvastatin in patients with stable coronary heart disease. It found that higher-dose atorvastatin resulted in superior cardiovascular event reduction (DrugBank).
* **Meta-analyses:** Multiple meta-analyses have consistently confirmed the cardiovascular benefits of statins, including atorvastatin, across various patient populations, underscoring their role in both primary and secondary prevention of cardiovascular disease (NIH ODS).
The collective evidence from these and other studies establishes atorvastatin as a cornerstone therapy for lipid management and cardiovascular risk reduction.
Like all medications, atorvastatin can cause side effects, though not everyone experiences them. Common side effects often tend to be mild and temporary. More serious side effects, while less common, can occur.
**Common side effects may include (FDA label, MedlinePlus):**
* Muscle pain, soreness, or weakness (myalgia)
* Diarrhea
* Nausea
* Headache
* Joint pain (arthralgia)
* Nasopharyngitis (common cold symptoms)
**Less common but serious side effects can include:**
* **Rhabdomyolysis:** A rare but serious condition involving muscle breakdown, which can lead to kidney damage. Symptoms include severe muscle pain, weakness, dark urine, and fever. This risk is increased with higher doses or when combined with certain other medications.
* **Liver problems:** Symptoms may include unusual fatigue, dark urine, yellowing of the skin or eyes (jaundice), upper right abdominal pain, or loss of appetite. Liver enzyme levels are typically monitored before and periodically during treatment.
* **Diabetes mellitus:** While statins significantly reduce cardiovascular risk, some studies have shown a small increase in the risk of new-onset diabetes, particularly in individuals with pre-existing risk factors.
* **Cognitive impairment:** Rare reports of memory loss or confusion have been associated with statin use, though these effects are generally mild and reversible upon discontinuation.
* **Allergic reactions:** Swelling of the face, lips, tongue, or throat; difficulty breathing; rash.
Report any unusual or severe symptoms to a healthcare professional promptly. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Several important warnings and precautions should be considered before and during atorvastatin treatment (FDA label, Mayo Clinic):
* **Liver function monitoring:** Liver enzyme levels should be checked before starting atorvastatin and periodically thereafter, especially if symptoms of liver injury develop. Use with caution in patients who consume substantial quantities of alcohol or have a history of liver disease.
* **Muscle pain and weakness:** Patients should be advised to report any unexplained muscle pain, tenderness, or weakness, particularly if accompanied by fever or malaise. These could be signs of rhabdomyolysis, a serious muscle condition.
* **Drug interactions:** Atorvastatin is metabolized by CYP3A4, and its levels can be significantly affected by inhibitors or inducers of this enzyme. Co-administration with certain medications can increase the risk of muscle toxicity (see 'Do Not Mix' section).
* **Kidney impairment:** Use with caution in patients with severe renal impairment.
* **New-onset diabetes:** Statins have been shown to increase HbA1c and fasting serum glucose levels in some patients, potentially leading to new-onset diabetes. However, the cardiovascular benefits generally outweigh this small risk.
* **Hemorrhagic stroke:** In studies, a higher incidence of hemorrhagic stroke has been observed in patients without coronary heart disease who were receiving atorvastatin compared to placebo. The overall benefit-risk balance for these patients, however, remains favorable.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Atorvastatin is contraindicated in certain situations due to potential risks (FDA label, DrugBank):
* **Active liver disease:** Including unexplained persistent elevations of serum transaminases.
* **Pregnancy:** Atorvastatin can cause fetal harm when administered to a pregnant woman. The drug should not be used in pregnant women. Women of childbearing potential should use effective contraception during treatment.
* **Lactation:** Atorvastatin is contraindicated during breastfeeding, as it is unknown if it is excreted in human milk, but serious adverse reactions in nursing infants are possible.
* **Hypersensitivity:** Patients with a known hypersensitivity to atorvastatin or any component of its formulation.
This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Combining atorvastatin with certain medications or substances can increase the risk of adverse effects, particularly muscle toxicity and rhabdomyolysis, or affect the efficacy of atorvastatin (FDA label, Examine.com):
* **Strong CYP3A4 inhibitors:** Medications such as itraconazole, ketoconazole, clarithromycin, telithromycin, protease inhibitors (e.g., ritonavir, lopinavir/ritonavir), boceprevir, telaprevir, nefazodone, and cyclosporine can significantly increase plasma concentrations of atorvastatin, increasing the risk of adverse reactions.
* **Gemfibrozil, other fibrates, and high-dose niacin (>1 gram/day):** These agents, when co-administered with statins, increase the risk of muscle adverse events, including rhabdomyolysis.
* **Colchicine:** Cases of myopathy, including rhabdomyolysis, have been reported with co-administration of colchicine and atorvastatin.
* **Grapefruit juice:** Consumption of large quantities of grapefruit juice (more than 1.2 liters/day) can increase the plasma concentrations of atorvastatin and should be avoided or consumed moderately.
* **Antacids (containing magnesium and aluminum hydroxide):** While not strictly 'do not mix', these can decrease plasma concentrations of atorvastatin. It is generally advised to take them at least 2 hours apart.
* **Oral contraceptives:** Co-administration with atorvastatin has been shown to increase the area under the curve (AUC) values for norethindrone and ethinyl estradiol. This may need to be considered when selecting an oral contraceptive.
* **Warfarin:** Atorvastatin may have a modest effect on the prothrombin time (INR) in patients receiving warfarin. INR should be monitored when atorvastatin is initiated or discontinued.
Always inform your healthcare provider about all medications, supplements, and herbal products you are taking. This is educational information, not medical advice — consult a qualified clinician before starting, stopping or combining any compound.
Atorvastatin can be taken at any time of day, with or without food. Although cholesterol synthesis primarily occurs at night, atorvastatin has a relatively long half-life, allowing for once-daily dosing with consistent efficacy regardless of the time of administration. It is common practice for some clinicians to recommend taking it in the evening (Examine.com). Adherence is crucial for the effectiveness of the medication, so choosing a time that is easy to remember and consistent is often recommended (NIH MedlinePlus). If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next dose. Do not double doses.
Source for this section: Sources for When should you take Atorvastatin?: Jumps to this entry in the sources and references list at the end of the page.
What interacts with Atorvastatin?
| Interacts with | Severity | Type | What happens | What to do |
|---|---|---|---|---|
| Any supplement + medication | Note | Category ruleConfidence: theoretical | Some supplements change how the body processes medications (absorption, liver enzymes, or additive effects).Source pending | Specific pairs are checked against a licensed drug database and shown with their own severity. Always confirm with your provider or pharmacist. |
| Any vitamin + medication | Note | Category ruleConfidence: theoretical | Certain vitamins interact with specific medications (e.g., vitamin K with blood thinners).Source pending | Specific pairs are checked against a licensed source; confirm with your provider. |
| Rapamycin | Caution | Compound pairConfidence: theoretical | Both metabolized by CYP3A4; rapamycin can raise statin levels and myopathy risk.Source pending | Separate dosing and monitor for muscle symptoms. |
| Berberine | Caution | Compound pairConfidence: theoretical | Berberine inhibits CYP3A4 and P-glycoprotein, raising statin levels and myopathy risk.Source pending | Separate dosing and monitor for muscle pain; consider lower statin dose. |
| CoQ10 (Ubiquinol) | Complementary | Compound pairConfidence: theoretical | Statins block CoQ10 biosynthesis via the mevalonate pathway; supplementing may reduce muscle symptoms.Source pending | Consider 100–200 mg CoQ10 daily while on a statin. |
| Ubiquinol | Complementary | Compound pairConfidence: theoretical | Statins deplete CoQ10; ubiquinol replenishes it.Source pending | Consider 100 mg ubiquinol daily. |
Frequently asked questions about Atorvastatin
Atorvastatin is a medication. It is also known as lipitor. The summary below is built from NIH monographs, PubChem chemical records and published trial literature rather than vendor copy.
Atorvastatin is commonly discussed in the context of the goals discussed on its profile page. Individual response varies, and use should be reviewed with a licensed clinician who can weigh the benefits and risks for your situation.
For Atorvastatin, it is typically taken evening and its approximate half-life is 14 hours, which influences dosing frequency. Always follow the specific dose your clinician or the product label prescribes.
Atorvastatin carries potential side effects and drug interactions, documented in NIH, Mayo Clinic, and FDA label sources. Atorvastatin is classified as a controlled substance in some jurisdictions, so legal status and prescribing rules apply. Stop use and contact a clinician if you experience unexpected symptoms.
Interaction risk for Atorvastatin comes from the rest of the stack: other medications, prescription medicines, hormone therapy and peptides. Because Atorvastatin is usually taken evening, most avoidable conflicts come from what else lands in that same window. With a reported plasma half-life near 14 hours, separating doses can change the picture as much as removing one. Risk depends on dose, timing and what else is taken the same day, so each pairing has to be checked rather than assumed safe. The free checker at https://doseroutine.com/interaction-checker covers Atorvastatin with no sign-up.
There is no single answer for Atorvastatin plus TRT. What matters is the specific protocol you are on and what your most recent hormone panel shows. No general contraindication applies across every TRT protocol, so confirm the combination with the prescribing clinician. See the free TRT interaction reference: https://doseroutine.com/trt-supplement-interactions
Pairing Atorvastatin with peptides has to be assessed one peptide at a time, because GLP-1 agonists, secretagogues, healing peptides and melanocortins do not share an interaction profile. Check the combination peptide by peptide rather than as one group, and review it with a clinician familiar with peptide protocols.
With a plasma half-life near 14 hours, once-daily dosing is the usual pattern for Atorvastatin. It is typically taken evening. Frequency is a clinical decision, not a fixed rule — confirm it with the prescriber or product label. Comparison of apps that keep a schedule like this: https://doseroutine.com/best-dose-tracking-apps
With a plasma half-life near 14 hours, a single missed dose of Atorvastatin usually has a smaller effect on overall exposure than an irregular pattern of missed doses does. Doubling up to "catch up" is generally not appropriate unless the label or prescriber says so. Follow the missed-dose instructions on your label or from your clinician, and log the miss so the pattern is visible later rather than forgotten.
For Atorvastatin the useful record is the dose, the time it was actually taken, and what else was taken in the same window. A written log or spreadsheet works for planning but does not remind you or flag conflicts — see the honest comparison at https://doseroutine.com/vs/spreadsheet and the wider roundup at https://doseroutine.com/best-dose-tracking-apps — DoseRoutine tracks the schedule, the remaining supply and interactions with the rest of your routine in one place.
Which studies looked at Atorvastatin?
Peer-reviewed research indexed in PubMed. Each entry links to the original record.
- 1.Intensive lipid lowering with atorvastatin in patients with stable coronary disease(opens PubMed in a new tab)N Engl J Med · 2005 · PMID 15755765 · https://pubmed.ncbi.nlm.nih.gov/15755765/
- 2.Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial(opens PubMed in a new tab)Diabetes Metab J · 2024 · PMID 38763510 · https://pubmed.ncbi.nlm.nih.gov/38763510/
Sources cited on this page
Specific documents referenced by the numbered markers above. Each number matches the marker in the text.
- PubChem CID 656846(opens in a new tab)National Center for Biotechnology Information · pubchem.ncbi.nlm.nih.gov/compound/656846
Verify at
Publisher search links for Atorvastatin. These are places to check the information — they are not citations, so they are not numbered.
- MedlinePlus(publisher search, opens in a new tab)U.S. National Library of Medicine · publisher search
- FDA-approved labeling (DailyMed)(publisher search, opens in a new tab)U.S. Food and Drug Administration · publisher search
- DrugBank(publisher search, opens in a new tab)DrugBank Online · publisher search
- Mayo Clinic(publisher search, opens in a new tab)Mayo Clinic · publisher search
- Cochrane Library(publisher search, opens in a new tab)Cochrane · publisher search
- Examine.com(publisher search, opens in a new tab)Examine.com · publisher search
- NIH Office of Dietary Supplements(publisher search, opens in a new tab)National Institutes of Health · publisher search
- PubMed literature search(publisher search, opens in a new tab)National Library of Medicine · publisher search
- Wikipedia entry(publisher search, opens in a new tab)Wikipedia · publisher search
DoseRoutine compiles summaries from publicly available scientific and regulatory references. Always verify important decisions with a licensed clinician. How we source and review this information.
What is the short answer on Atorvastatin?
Plain-text summary, safe to quote verbatim:
Atorvastatin, marketed often under the brand name Lipitor, is a member of the drug class known as statins or HMG-CoA reductase inhibitors. It is a prescription medication primarily used to lower high levels of cholesterol and triglycerides in the blood.
Source: DoseRoutine — https://doseroutine.com/library/atorvastatin
Cite this page
Using this in an article, AI answer, or research note? Please attribute:
DoseRoutine. (2026). Atorvastatin — Overview, Benefits & Side Effects. Retrieved from https://doseroutine.com/library/atorvastatin
What compounds are similar to Atorvastatin?
Others in the medication category or studied for the same goals.